Clinical Trials Browser

Unknown × Urogenital Neoplasms × Gemcitabine × Clear all

NCT05030077 2021-09-01

Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma

Phase 2 Unknown

Carcinoma, Transitional Cell, Urogenital Neoplasms